https://scholars.lib.ntu.edu.tw/handle/123456789/587980
標題: | Idarucizumab-facilitated intravenous thrombolysis in acute ischemic stroke: A therapeutic strategy requiring further investigation | 作者: | Hsiao Y.-J. Tsai Y.-T. LI-KAI TSAI Fang C.-W. |
關鍵字: | Dabigatran; Hemorrhagic transformation; Idarucizumab; Ischemic stroke; Thrombolysis | 公開日期: | 2018 | 卷: | 394 | 起(迄)頁: | 144-145 | 來源出版物: | Journal of the Neurological Sciences | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054163017&doi=10.1016%2fj.jns.2018.09.017&partnerID=40&md5=2e1aadccc3e668233c88f9208bcdeda5 https://scholars.lib.ntu.edu.tw/handle/123456789/587980 |
ISSN: | 0022510X | DOI: | 10.1016/j.jns.2018.09.017 | SDG/關鍵字: | dabigatran; idarucizumab; idarucizumab; monoclonal antibody; anticoagulation; artificial embolization; blood clot lysis; brain hemorrhage; brain ischemia; clinical effectiveness; clinical practice; clinical trial (topic); disease severity; drug effect; drug safety; evidence based practice; hemorrhagic transformation; human; laboratory test; Letter; low risk patient; outcome assessment; percutaneous thrombectomy; phase 3 clinical trial (topic); priority journal; risk assessment; risk factor; stroke patient; treatment indication; brain ischemia; cerebrovascular accident; complication; fibrinolytic therapy; immunology; procedures; Antibodies, Monoclonal, Humanized; Brain Ischemia; Clinical Trials as Topic; Dabigatran; Humans; Stroke; Thrombolytic Therapy |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。